About Pacific Biosciences of California, Inc.
Pacific Biosciences of California, Inc. is an American biotechnology company founded in 2004 that develops and manufactures systems for gene sequencing and some novel real time biological observation. PacBio has two principal sequencing platforms: single-molecule real-time sequencing, based on the properties of zero-mode waveguides and sequencing by binding chemistry, which uses native nucleotides and scarless incorporation for DNA binding and extension.
2BB score and signals
Pacific Biosciences of California, Inc.’s current 2BB score is 47 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|
| Activity | 51 | Moderate |
| Momentum | 46 | Stable |
| Financial strength | 6 | Very Weak |
| Quality | 100 | Very Strong |
| Risk | 53 | Moderate |
Company facts
| CEO | Christian Henry |
| Headquarters | Menlo Park, California, United States |
| Founded | 2004 |
| Employees | 485 |
| 52-week range | $1.07 – $2.73 |
Recent earnings
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|
| 2027-02-09 | — | -0.1341 | — | $45.34M |
| 2026-11-03 | — | -0.1323 | — | $41.11M |
| 2026-08-05 | — | -0.1297 | — | $40.87M |
| 2026-05-07 | -0.12 | -0.1375 | $37.18M | $40.79M |
Related companies
